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ABSTRACT
The lung is one of the most immunologically challenged
organs and can be affected by a number of pathogens,
including bacteria, virus, fungi, and parasites. The de-
velopment and chronicity of pulmonary infection are de-
termined by the early innate response to the patho-
genic stimuli and are regulated at multiple levels. Initial
studies have indicated that the interaction of Notch and
Notch ligands plays a critical role during development,
and further, the Notch system is an important bridge
between APCs and T cell communication circuits. APCs
are essential regulators of the innate immune re-
sponse. They can respond to PAMPs through PRRs,
which function in the recognition of pathogenic compo-
nents and play an important role in the innate and
adaptive immune response. T cells are essential regu-
lators of adaptive immune responses and infectious
diseases. However, the role of the Notch system in the
cross-talk between APC and T cells during pulmonary
infection is still poorly understood. In the present re-
view, we discuss recent findings that explore the
mechanisms underlying the role of Notch signaling in
the linkage of innate and adaptive immunity, including
pulmonary infection though PPRs and Notch activation.
J. Leukoc. Biol. 92: 59–65; 2012.
Introduction
The induction of immune responses during infection is ini-
tially sensed by the host’s innate immune system and triggers a
rapid, antiinfectious response that involves the release of pro-
inflammatory cytokines and eventually leads to the activation
of the adaptive immune response [1]. The first line of defense
is initiated when cellular PRRs recognize PAMPs [2, 3]. Recog-
nition of PAMPs by PRRs rapidly triggers an array of antimi-
crobial immune responses through the induction of various
inflammatory cytokines, chemokines, and type I IFNs [1, 4].
Several families of PRRs, including TLRs, RIG-I-like receptors,
nucleotide-binding oligomerization-like receptors, and DNA
receptors (cytosolic sensors for DNA), are known to play a cru-
cial role in host defense [5].
APCs, DCs, and macrophages can respond to pathogens
through PRRs, which function in the recognition of infectious
components and play an important role in the innate and
adaptive immune responses [6, 7]. The innate immune re-
sponse by APCs is initiated quickly to protect from overwhelm-
ing infectious organisms but with time, can also activate the
adaptive immune response to the invading pathogens [8]. T
cell differentiation is the hallmark of the initiation of the
adaptive immune response [9]. Recent data have indicated
that the controlled expression of Notch receptor proteins on
T cells is essential for normal T cell development and matura-
tion [10]. The connection between these PRRs and Notch
pathways has helped to define the complex role of APCs in
the regulation of T cell differentiation [11, 12]. We here re-
view recent advances concerning the role of Notch signaling
in T cell differentiation during infection and present our re-
cent findings focusing on Notch functions in infectious mod-
els, which include mycobacterium antigen and influenza virus.
NOTCH SYSTEM IN T CELLS
Notch is a receptor system, which was originally shown to be
involved in cell differentiation and survival [13]. Notch signal-
ing is initiated by the ligand engagement of the Notch recep-
tor. There are five mammalian ligands (Dll1, -3, and -4 and
Jagged-1 and -2), each of which can promiscuously activate any
of the four Notch receptors (Notch1, -2, -3, and -4) [12, 14].
Upon binding by Dll or Jagged ligands, Notch undergoes pro-
teolytic cleavage catalyzed by a disintegrin and metalloprotei-
nase proteases and the GSI, leading to the translocation of the
N-ICD into the nucleus. N-ICD interacts with the transcrip-
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tional repressor, RBP-J. The N-ICD interaction with RBP-J dis-
places transcriptional corepressors from RBP-J and also re-
cruits MAML protein. The new transcriptional complex of N-
ICD-RBP-J-MAML converts RBP-J from a repressor to a
transcriptional activator [12, 14–16].
In the last decade, it has been demonstrated that Notch sig-
naling pathways contribute to the hematopoietic and immune
systems, including roles in the development of embryonic he-
matopoietic stem cells and in multiple lineage decisions of de-
veloping lymphoid and myeloid cells [17]. Notch signaling
during lymphoid development has been studied extensively,
and its role in determining cell fate at many stages during T
cell development is well characterized [17]. Notch-mediated
responses have been shown to be involved in T cell lineage
maturation from double-negative pro-T cells to double-positive
CD4/CD8 T cells in the thymus [18–20]. Studies have
mapped out this latter mechanism in the thymus, which helps
to explain how T cells develop through the early differentia-
tion stages [21–25]. Other studies have shown that Notch sig-
naling is also involved in T cell differentiation into mature
CD4 and CD8 T cells [26, 27]. Mature CD4 T cells are
essential regulators of adaptive immune responses and inflam-
matory diseases. Upon antigenic stimulation by APCs through
MHC class II proteins, naive CD4 T cells become activated,
expand, and differentiate into various Teff helper subsets,
termed Th1, Th2, Th17, and Tregs, which are each character-
ized by the production of distinct cytokines and effector func-
tions [17]. On the other hand, CD8 T cells, responding to
specific peptide-MHC complexes through MHC class I pro-
teins, differentiate into CTLs and memory cells [17]. Table 1
summarizes and provides references for some of the recent
studies regarding the role of Notch in T cell immune re-
sponses. For a more extensive overview of Notch signaling, we
refer to refs. [13, 44, 45].
NOTCH IN Th1 IMMUNE RESPONSE
Th1 cells normally produce the proinflammatory cytokine
IFN- to stimulate the clearance of intracellular infections in-
duced by microbial and viral infections, whereas an excessive
Th1 response can cause autoimmunity [46]. A number of stud-
ies have demonstrated that Notch proteins are important in
the induction of Th1 responses. In the presence of functional
MyD88, PAMP binding to TLR up-regulates Dll4, which causes
the differentiation of naïve Th cells to a Th1 phenotype [21,
28, 29, 47]. Furthermore, when Dll ligands are overexpressed
on APC or are cross-linked as fusion proteins, they also pro-
mote Th1 cell differentiation [22]. Th1 cell responses were
reduced in vivo following the administration of blocking Dll-Fc
fusion proteins or of a neutralizing antibody, which was spe-
cific for Dll1 [22, 30, 31]. However, the functional difference
in Th1 cell differentiation, driven by Dll1 and Dll4, is still
poorly understood. Notch1 can regulate Tbx21 directly
through complexes formed on the Tbx21 promoter (of the
T-bet gene), which plays an important role in Th1 cell differ-
entiation and IFN- production [32]. Also, in this study, ecto-
pic expression of activated Notch1 restored Tbx21 transcrip-
tion and IFN- production in Th1 cells that had the Notch
pathway inhibited by the use of GSI inhibitors [32]. In con-
trast, another study in Notch signal-deficient mice demon-
strated a normal Th1 cell response, thus questioning the role
of endogenous Notch in normal Th1 cell differentiation [25].
Reconciliation of these diverging results will require further
studies. Another factor affecting Th1 differentiation is IL-12, as
naïve Th cells are skewed to the Th1 phenotype in the pres-
ence of exogeneously added IL-12 [48]. When IL-12 is absent
or present at suboptimal levels, notch Dll ligands can positively
affect Th1 cell differentiation [31]. However, genetic inactiva-
tion of RBP-J or Notch1 and Notch2 had no effect on Th1 cell
differentiation [17, 21, 25, 26], suggesting that Notch signaling
is not essential but has an accessory role in Th1 cell differenti-
ation.
NOTCH IN Th2 IMMUNE RESPONSE
Not only is IL-4 important for the differentiation of Th2 cells,
but once differentiated, these Th2 cells themselves produce
IL-4, which stimulates the clearance of parasite infections [46].
In contrast, an excessive Th2 response can lead to allergic re-
sponses. Notch signaling has also been implicated in Th2 cell
differentiation. In fact, genetic loss of T cell function studies
have shown that Notch is essential for Th2 cell responses un-
der various physiologically relevant conditions, including para-
site infections [21, 25, 26]. In contrast to Th1 cell differentia-
tion, the differentiation of naïve Th cells to a Th2 phenotype
occurred in the absence of functional MyD88, when Jagged
was constitutively expressed [21, 30]. In particular, the expres-
sion of Jagged is induced in DCs in response to Th2-skewed
conditions, including parasites, allergens, or proinflammatory
mediators, such as PGE2 [21, 36, 49]. Th2 cell responses are
severely diminished in the absence of T cell-specific expression
of Notch receptors 1 and 2 and pan-Notch inhibition medi-
ated by RBP-J knockout or expression of a DNMAML [25, 26,
50], suggesting that Th2 cell differentiation by the Notch path-
way is dependent on RBP-J. This requirement for RBP-J ex-
pression in Th2 cell differentiation stands in contrast to its
accessory role in Th1 differentiation as mentioned above. Re-
cent studies indicated that Notch promotes activity of the up-
stream GATA3 promoter, resulting in transcription of the
GATA3 gene, a necessary transcription factor for Th2 cell dif-
ferentiation [21]. Fang et al. [27] demonstrated that Notch
regulates GATA3 expression by augmenting amounts of the
alternative exon 1a transcript in CD4 T cells. Also, GATA3
might help to render the IL-4 enhancer, DNase I HS (HS5)
accessible to Notch, which then results in increased IL-4 gene
expression and protein levels [21, 27]. Furthermore, Notch
directly regulates transcription of the IL-4 gene by binding to
the HS5 enhancer [11]. Taken together, these data provide
two molecular mechanisms by which Notch signaling can pro-
mote Th2 cell differentiation, namely, GATA3-dependent and
GATA3-independent pathways.
NOTCH IN Th17 IMMUNE RESPONSE
In addition to the well-described Th1 and Th2 cell subsets,
IL-17-producing T cells have recently been described and
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named Th17 cells [51, 52]. DC-derived Notch ligand Dll4 reg-
ulates the differentiation of naïveTh cells into Th17 cells
through a MyD88-dependent pathway, in response to Mycobac-
terium antigens [37], and also up-regulates Th17 cell-specific
transcription factor RORt [53]. A recent study revealed a di-
rect connection between Dll4-induced RBP-J and RORt
through a consensus RBP-J-binding site on the RORt pro-
moter, similar to Th2 differentiation [53]. In an EAE model,
pathogenic Th1 and Th17 cells develop in the CNS, causing
autoimmunity. GSI-mediated inhibition of Notch signaling in
this disease model resulted in reduced Th1 and Th17 cyto-
kines [32, 33]. In addition, specific antibodies against Dll1,
TABLE 1. Summary of References for Recent Studies Regarding the Role of Notch in T Cell Immune Responses
APC Notch ligand Notch receptor In vivo model Usage Reference
Th1 DC (BM) Dll4 No LPS treatment [21]
plate-bound Dll1-Fc Dll1 Notch 3 Yes (Leishmania
major)
DII1-Fc injection into L.
major-infected mice
[22]
DC (BM) Dll4 Yes (RSV) MyD88-deficient mice [28]
Dll1 or Dll4 retrovirus-
transduced IL-12/
DCs
Dll1 Dll4 No Forced expression of Dll [29]
Jagged1-Fc and Delta1-
Fc-fusion2 proteins
Dll1 Jagged1 Yes (EAE) In vivo blockade of
Jagged1 and Dll1
[30]
CD8 DCs (spleen) Dll4 No LPS treatment [31]
Notch 1 Yes (EAE) GSI inhibitor treatment [32]
Notch 3 Yes (EAE) In vivo blockade of
Notch 3
[33]
Macrophage Dll1 Yes (influenza
virus)
In vivo blockade of Dll1 [34]
DC (BM) Dll4 Yes (RSV) In vivo blockade of Dll4 [35]
Th2 DC (BM) Jagged1 Notch 1 No LPS treatment [21]
Yes (L. major) Mice that lack Notch
signaling in CD4 T
cells
[25]
Notch 1 Notch 2 No RBP-J-deficient (RBPfl/-
CD4Cre) mice
[26]
Notch 1 No ROSA26-DNMAML mice
with CD4-cre mice
[27]




Th17 DC (BM) Dll4 Yes (Mycobacterial
granuloma)
TLR9-deficient mice and
in vivo blockade of
Dll4
[37]
























CD8 T DC (BM) infected
with a retrovirus
encoding Dll1
Dll1 Notch 2 No Notch2f/fE8I-Cre mice [40]
Notch 1 No Notch1 antisense mice [41]
Dll1 Notch 1 Yes (asthma) Administration of
Dll1-Fc
[42]
Macrophage Dll1 Yes (influenza
virus)
In vivo blockade of Dll1 [34]
DC (BM) Dll4 Yes (RSV) In vivo blockade of Dll4 [35]
T cells No Hes-1-deficient mice [43]
BM, Bone marrow; NOD, nucleotide-binding oligomerization.
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which attenuated EAE, had the opposite effect, caused by anti-
bodies against Jagged1, which exacerbated EAE [30]. These
results suggest that Dll ligands on DCs seem to be involved in
the promotion of pathogenic Th1 and Th17 cells, whereas Jag-
ged ligands might suppress autoimmunity [17].
NOTCH IN Treg IMMUNE RESPONSE
Tregs, which specifically express the forkhead family transcrip-
tion factor Foxp3, are essential for the maintenance of immu-
nological self-tolerance and immune homeostasis [54]. TGF-
is a key cytokine that induces Foxp3 expression and a regula-
tory phenotype in peripheral T cells (Tregs) [54]. Several re-
ports showed that Notch signaling can enhance Treg differen-
tiation and function in vitro [17, 55]. For example, Samon et
al. [38] demonstrated that Notch1 and TGF- signaling path-
ways cooperatively regulate Foxp3 expression and Treg mainte-
nance in vitro and in vivo. Another report showed that expo-
sure of Tregs to Jagged2-expressing hematopoietic progenitor
cells resulted in Treg proliferation and prevented the develop-
ment of diabetes in an experimental autoimmune disease
model in mice [17, 39]. Collectively, these results indicate that
Notch signaling has a critical role in sustaining Foxp3 expres-
sion in Tregs to maintain their immune-suppressive function.
Thus, Notch signaling has been linked to many aspects of pe-
ripheral T cell immune responses, as well as to T cell develop-
ment. For some of these functions, Notch may not be abso-
lutely required. However, Notch signaling does appear to be
critical in supporting immune responses. There is clearly more
work needed, especially in in vivo models, to understand the
full spectrum of Notch functions in the linkage between in-
nate and adoptive immunity.
NOTCH IN OTHER T CELL IMMUNE
RESPONSE
The CD8 T cell is also an essential component of the adap-
tive immune response to many pathogens [56]. Upon engage-
ment with antigens, naïve CD8 T cells rapidly expand and
differentiate into CTLs, producing cytokines, such as IFN-
and the effector molecules, perforin and granzyme B [57].
Tbx—T-bet and Eomes—are important inducers of genes in-
volved in the acquisition of CTL function and in the respon-
siveness to cytokines that regulate the survival of long-lived
memory T cells [58, 59]. Recent data demonstrated that sig-
naling mediated by Dll1 and Notch2 was required for full
cytotoxic activity of CTLs and that Notch2 directly con-
trolled transcription of the gene encoding granzyme B,
which is independent of Eomes [40]. Another study indi-
cated that Notch1 regulates the expression of Eomes, perfo-
rin, and granzyme B through N-ICD binding to the promot-
ers of these effector molecules [41]. In an in vivo allergic
asthma model, Notch1 is expressed on memory CD8 Teffs,
and Dll1 expression is an effective inhibitor of allergic
asthma responses [42]. However, the difference between
Notch1 and Notch2 in the regulation of these effector mol-
ecules is not clearly understood.
Unlike conventional  T cells,  T cells constitute a whole
system of functionally specialized subsets that are involved in
the innate immune responses against tumors and pathogens
and the regulation of immune responses, cell recruitment and
activation, and tissue repair [60, 61]. In addition to Th17 cells,
there is accumulating evidence that  T cells could be the
major source of IL-17 in various murine models of infection
including Mycobacterium tuberculosis, Escherichia coli, and Listeria
monocytogenes [62, 63]. Recent published data clearly demon-
strated that Notch ligand Dll4 expression is correlated with the
development of IL-17-producing  T cells [43]. The impor-
tance of Notch signaling in IL-17-producing  T cells in in
vivo models remains unknown.
THE ROLE OF NOTCH PATHWAY FOR
REGULATION OF BACTERIAL INFECTION
It has been estimated that one-third of the world’s population
is infected with M. tuberculosis and that tuberculosis is one of
the most well-characterized, bacteria-induced granulomagenic
diseases [64]. Whereas the mechanism of granuloma forma-
tion is not clear, this distinct cellular response is considered a
histologic hallmark for a protective immune response, involv-
ing innate and adaptive immunity. Our group has studied
Dll4, the primary Notch ligand, which is up-regulated by myco-
bacteial infection of DCs. When Dll4 was specifically blocked
in vivo during mycobacteria-induced pulmonary granuloma
formation, Th17 cellular responses were inhibited significantly,
and larger granulomas were observed [37]. Moreover, in in
vitro experiments, anti-Dll4 antibody specifically blocked IL-17
production by CD4 T cells, whereas overexpression of Dll4
augmented IL-17 production by CD4 T cells, suggesting that
Dll4 plays an important role in promoting Th17 activity during
a mycobacterial challenge [37] (Fig. 1A). These data suggest
that an understanding of Dll4 regulation of Th17 responses
through Notch may provide mechanistic approaches for modi-
fying and controlling the immune response induced by the
Th17 phenotype, including pathogenesis of not only bacterial
and fungus infection but also autoimmune disease, allergic
responses, and cancer.
THE ROLE OF NOTCH PATHWAY FOR
REGULATION OF VIRAL INFECTION
Influenza viruses cause annual epidemics and occasional pan-
demics that have claimed the lives of millions [65]. Innate and
acquired immunity is essential for protection against influenza
virus, and it has been suggested that Notch and Notch ligands
may provide a key bridge between these two arms of the im-
mune system. Our recent data demonstrated that macro-
phages, but not DCs, increased Notch ligand Dll1 expression
following influenza virus stimulation [34]. Dll1 expression on
macrophages was dependent on the RIG-I-induced type-I IFN
pathway and not on the TLR3-Toll-IL-1R domain-containing
adaptor-inducing IFN- pathway. IFN-R/ mice failed to
induce Dll1 expression on lung macrophages and had en-
hanced mortality during influenza virus infection. Further-
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more, specific neutralization of Dll1 during influenza virus
challenge induced higher mortality, impaired viral clearance,
and decreased levels of IFN-. Dll1 expression on macro-
phages specifically regulates IFN- levels from CD4 and
CD8 T cells in vitro [34] (Fig. 1B). These data suggest that
Notch signaling through macrophage-expressing Dll1 is critical
in providing an antiviral response during influenza infection
and provides a link between innate and acquired immunity.
The Flavell group [21] has shown that Delta ligands on APCs
promote Th1 differentiation, whereas the Yasutomo group
[22] has demonstrated that Dll1 interaction with Notch3 on T
cells promotes development toward the Th1 phenotype. Also,
it has been shown that CD8 DCs can direct Th1 differentia-
tion by an IL-12-independent and Dll4-dependent mechanism
[31]. Thus, our work agrees with this notion that Dll ligands
are important in driving Th1 cell differentiation. However, we
are still investigating the type of Notch receptor involved in
our model system.
Our colleagues have also studied the role of Notch signaling
during RSV infection, which is a leading cause of bronchiolitis,
pneumonia, and allergic asthma in young children worldwide.
Notch ligand Dll4 was up-regulated on bone marrow-derived
DCs after RSV infection through a MyD88-dependent pathway
[28]. When specifically blocking Dll4 in vivo by passive immu-
nization during RSV infection, a more intense pathogenic re-
sponse was observed that included increases in airway hyper-
reactivity and mucus hypersecretion [35]. This response was
characterized by elevated Th2 cytokine production, which
could be reversed in vitro by culturing T cells under condi-
tions of overexpression of Dll4 [35]. The different Notch li-
gand expression patterns caused by influenza virus and RSV
might be a result of different PRRs. Whereas the main PRR
Figure 1. Schematic representation of the
role of Notch ligands in our models. (A)
The role of Notch ligand (Dll4) on a my-
cobacterium-induced granuloma model.
In vivo granuloma formation induced by
bacillus Calmette-Guérin (BCG)/myco-
bacterium antigen demonstrates larger
granuloma formation in anti-Dll4 anti-
body-treated mice with decreased num-
bers of Th17 cells and mDCs and an in-
creased number of macrophages (M) in
the lungs when compared with lung gran-
ulomas from mice treated with control
antibody. The decreased expression of
Dll4 led to the abrogation of the Th17
phenotype in the anti-Dll4 antibody-
treated mice with a concomitant increase
in granuloma size. The TLR9 signaling
pathway, through MyD88 on DCs, plays a
central role by up-regulating Dll4 and
Th17-related cytokines, including IL-17,
IL-6, IL-23(p19/p40), and TNF-, in re-
sponse to Mycobacterium antigens. IT, In-
tratracheal; IV, i.v.; IP, i.p.; PPD, myco-
bacteria-derived, purified protein deriva-
tive; mDC, myeloid DC. (B) The role of
the Notch ligand (Dll1) on the influenza
virus H1N1 infection model. Macro-
phages play an important role in regulat-
ing IFN- production from CD4 and
CD8 T cells through a RIG-I-induced
type-I IFN-dependent pathway (including
the JAK-STAT pathway), which up-regu-
lates the Notch ligand Dll1. Our in vivo
influenza H1N1 infectious model demon-
strates higher mortality and impaired vi-
ral clearance in anti-Dll1antibody-treated
mice with decreased IFN- production
when compared with control IgG-treated
mice. IN, Intranasal.
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signaling pathway for influenza virus is a RIG-I-induced type-I
IFN-dependent pathway in macrophages, which for RSV, is a
TLR-induced, MyD88-dependent pathway in DCs. However,
the specific mechanistic link governing the connection be-
tween each of the viral products and Notch signals remains
unknown. We are now investigating the role of Notch signal-
ing during herpes DNA virus infection.
CONCLUDING REMARKS
A number of recent studies clearly have demonstrated a criti-
cal role for Notch signaling in the regulation of APCs and T
cells, an important connection between the innate and adap-
tive immune response. Whereas the relevance of APC, PRRs,
and Notch in the activation of the mature immune system is a
story in its infancy, the data to date demonstrate how the ma-
turing immune system relies on a diverse set of molecules and
cell populations to fine-tune the system for the most appropri-
ate and least pathogenic responses. However, future studies
need to include more relevant in vivo studies to confirm and
expand the early findings of in vitro studies. One of our re-
cent findings indicated that Notch ligand Dll4 caused an in-
crease in the expansion of Th2 memory cells and a decrease
in effector cell proliferation in a parasitic study model [66].
This study suggests that the Notch pathway also contributes to
the different responses of memory and Teffs to Notch ligands,
whereas it has been well established that Notch ligands can
have opposing effects on T cell differentiation, depending on
the immune environment [21]. More in-depth studies using
mice that are deficient in each Notch and Notch ligand pro-
tein will provide data about how the different Notch ligands
(Delta and Jagged ligands) control the different types of T cell
responses during physiological conditions. Validation of the in
vitro data requires a number of in vivo studies using diverse
infectious disease models, which include bacteria, virus, para-
sites, and fungus, as well as autoimmune and allergy models.
Moreover, the cellular constituents of the lung immune system
of the lung are diverse and include not only leukocytes, such
as macrophages, DCs, neutrophils, mast cells, and lympho-
cytes, but also, it is clear that epithelial cells and fibroblasts
play critical roles in the lung defense system. Further knowl-
edge of the regulation of the Notch system in these cells and
contextual interactions between these populations may provide
mechanistic approaches for modifying and controlling the im-
mune response during infectious diseases in clinically relevant
translational studies.
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